Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Biopharm Knowledge Publishing | EvaluatePharma® Yearbook Company Performance Tables

EvaluatePharma® Yearbook Company Performance Tables

Benchmark a Changing Market

In a fast-changing pharmaceutical market it is vital to be able to measure company performance easily and accurately - find out which companies are winning in the areas that count and which are suffering in changing circumstances. The new EvaluatePharma® Yearbook gives you the information that you need, in context.

The Yearbook provides information and data of the highest quality, taken directly from the EvaluatePharma® database and it will enable you to:

Benchmark company revenue and expenditure

Analyse company performance

Assess mergers and acquisitions

Understand patent expiry issues

Match R&D spend to performance

Analyse sales by therapy area, licensing, acquisitions etc

Analyse winners and losers by therapy area

All of the detailed information in the Yearbook is put in context by explanations of the new pharmaceutical market place, how it works and how companies perform within it.

The Yearbook provides detailed information about the top 150 companies, including:

Revenue

Income

Growth

R&D expenditure

M&A activity

Patent expiry

Staffing levels

Expenditure

With 41 tables of detailed EvaluatePharma® information this 130 page report is edited by former Scrip Magazine Journalist Jacky Law.

It is essential reading for everybody in the pharmaceutical market from senior executives and corporate strategists, through marketing and sales departments to market analysts and pharmaceutical outsourcing companies.

August 2008
Table of Contents
Price: $2,392.00 / €1,600.25

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions